Search results for " Prophylaxis"

showing 10 items of 124 documents

Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediat…

2017

Summary Background The benefits and harms of continuous antibiotic prophylaxis (CAP) versus observation in patients with antenatal hydronephrosis (ANH) are controversial. Objective The aim was to determine the effectiveness of CAP for ANH, and if beneficial to determine the best type and regimen of antibiotic and the most harmful to provide guidance for clinical practice. Methods A systematic literature search was performed in databases including Medline, Embase, and Cochrane in June 2015. The protocol was prospectively registered to PROSPERO (CRD42015024775). The search started from 1980, when maternal ultrasound was first introduced into clinical practice. Eligible studies were critically…

DIAGNOSED HYDRONEPHROSISPRENATAL HYDRONEPHROSISmedicine.medical_specialtyPediatricsRENAL PELVIC DILATATIONCLINICAL-COURSEUrology030232 urology & nephrologyMEDLINEHydronephrosislaw.invention03 medical and health sciencesURINARY-TRACT-INFECTION0302 clinical medicineRandomized controlled triallawDETECTED HYDRONEPHROSIS030225 pediatricsmedicineAntenatal HydronephrosisHumansAntibiotic prophylaxisAdverse effectIntensive care medicineChildrenUrinary tract infectionbusiness.industryAntenatal hydronephrosisInfant NewbornJUNCTION OBSTRUCTIONAntibiotic ProphylaxisRegimenUrinary Tract InfectionsPediatrics Perinatology and Child HealthRISK-FACTORSEtiologyObservational studyPRIMARY VESICOURETERAL REFLUXFOLLOW-UPbusinessJournal of Pediatric Urology
researchProduct

Use of the KSVM-based system for the definition, validation and identification of the incisional hernia recurrence risk factors

2019

BACKGROUND: Incisional hernia is one of the most common complications after abdominal surgery with an incidence rate of 11 to 20% post laparotomy. Many different factors can be considered as risk factors of incisional hernia recurrence. The aim of this study is to confirm and to validate the incisional hernia recurrence risk factors and to identify and to validate new ones. METHODS: In the period from July 2007 to July 2017, 154 patients were selected and subjected to incisional hernia repair. The surgical operations were conducted under general anaesthesia. Patients received antibiotic prophylaxis when indicated, according to the hospital prophylaxis scheme. Inclusion criteria of the study…

Data AnalysisMaleAge FactorsDatasets as TopicIncisional hernia - Risk factors - Recurrence - KSVM.ComorbidityAnesthesia GeneralAntibiotic ProphylaxisMiddle AgedSensitivity and SpecificityBody Mass IndexMachine LearningSex Factorssurgical procedures operativeRecurrenceRisk Factorsincisional hernia risk factorsData MiningHumansIncisional HerniaFemale
researchProduct

Adaptation of Fusarium oxysporum and Fusarium dimerum to the specific aquatic environment provided by the water systems of hospitals.

2015

SPE IPM MERS EA; International audience; Members of the Fusarium group were recently detected in water distribution systems of several hospitals in the world. An epidemiological investigation was conducted over 2 years in hospital buildings in Dijon and Nancy (France) and in non-hospital buildings in Dijon. The fungi were detected only within the water distribution systems of the hospital buildings and also, but at very low concentrations, in the urban water network of Nancy. All fungi were identified as Fusarium oxysporum species complex (FOSC) and Fusarium dimerum species complex (FDSC) by sequencing part of the translation elongation factor 1- alpha (TEF-1a) gene. Very low diversity was …

FusariumVeterinary medicineEnvironmental EngineeringAntifungal AgentsCopper SulfateSodium Hypochlorite[SDV]Life Sciences [q-bio]Acclimatizationsoilborne fungibiofilmAgar plateopportunistic fungi03 medical and health scienceschemistry.chemical_compoundPeptide Elongation Factor 1FusariumWater SupplyBotanyFusarium oxysporum[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyColonizationWaste Management and DisposalSoil Microbiology030304 developmental biologyWater Science and TechnologyCivil and Structural Engineering0303 health sciencesbiology030306 microbiologyEcological ModelingDrinking Wateraquatic nicheTemperatureContaminationPhosphorus Compoundscolonizationbiology.organism_classificationSilicon Dioxidepreventive prophylaxisPollutionHospitalsFungicidechemistrySodium hypochloriteBiofilms[SDE]Environmental SciencesFranceAdaptationWater MicrobiologyWater research
researchProduct

Akutes Lungenversagen bei Malaria tropica in der Schwangerschaft: Erfolgreiche Behandlung durch extrakorporale CO2-Elimination

2008

Eine 32jahrige Schwangere (26. Schwangerschaftswoche) erkrankte am 6. Tag nach der Ruckkehr von einem Indonesienaufenthalt mit Fieber bis 42°C, hamolytischer Anamie (Hamoglobin 7,6 g/dl) und Thrombozytopenie (7000/µl). Es wurde eine Malaria diagnostiziert; eine Prophylaxe hatte sie nicht durchgefuhrt. Unter antiparasitarer Chemotherapie mit Chloroquin, Chinin und Pyrimethamin kam es zur Elimination der Parasiten (Makrogametozyten von Plasmodium falciparum) aus dem peripheren Blut. Im weiteren Verlauf entwickelte sich jedoch ein progredientes Lungenversagen und eine therapierefraktare Pneumonie, die zu einem »adult respiratory distress syndrome« (ARDS; Morel-Stadium 4) fuhrten. Bei drohendem…

GynecologyArtificial ventilationPediatricsmedicine.medical_specialtyARDSQuinineRespiratory distressbusiness.industryMalaria prophylaxismedicine.medical_treatmentGeneral Medicinemedicine.diseasePneumoniaRespiratory failuremedicinebusinessMalariamedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients

2019

Haemophilia Apersonalised prophylaxis
researchProduct

Healthcare associated infection: novel strategies and antimicrobial implants to prevent surgical site infection

2010

This report is based on a Hygienist Panel Meeting held at St Anne's Manor, Wokingham on 24–25 June 2009. The panel agreed that greater use should be made of antiseptics to reduce reliance on antibiotics with their associated risk of antibiotic resistance. When choosing an antiseptic for clinical use, the Biocompatibility Index, which considers both the microbiocidal activity and any cytotoxic effects of an antiseptic agent, was considered to be a useful tool. The need for longer and more proactive post-discharge surveillance of surgical patients was also agreed to be a priority, especially given the current growth of day-case surgery. The introduction of surgical safety checklists, such as…

Healthcare associated infectionsmedicine.medical_specialtyProsthesis-Related Infectionsmedicine.drug_classAntisepsisReviewBacterial AdhesionAntibiotic resistanceAnti-Infective AgentsAntisepticmedicineHumansSurgical Wound InfectionProsthesis-Related InfectionAntibiotic prophylaxisIntensive care medicineSuturesbusiness.industryGeneral MedicineAntibiotic ProphylaxisAntimicrobialSurgeryAntimicrobial suturesBiofilmsAnti-Infective Agents LocalSurgerybusinessAnti-Infective AgentsSurgical site infectionSurgical site infection
researchProduct

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19

2020

Purpose To assess efficacy and safety of chloroquine (CQ)/hydroxychloroquine (HCQ) for treatment or prophylaxis of COVID-19 in adult humans. Materials and methods MEDLINE, PubMed, EMBASE and two pre-print repositories (bioRxiv, medRxiv) were searched from inception to 8th June 2020 for RCTs and nonrandomized studies (retrospective and prospective, including single-arm, studies) addressing the use of CQ/HCQ in any dose or combination for COVID-19. Results Thirty-two studies were included (6 RCTs, 26 nonrandomized, 29,192 participants). Two RCTs had high risk, two ‘some concerns’ and two low risk of bias (Rob2). Among nonrandomized studies with comparators, nine had high risk and five moderat…

ICU Intensive care unit;medicine.medical_treatmentCritical Care and Intensive Care MedicineRR Risk Ratio0302 clinical medicineChloroquineRCT Randomized clinical trialMedicineHCQ Hydroxychloroquine;Prospective StudiesProspective cohort studyChloroquine COVID-19 Hydroxychloroquine Mortality SARS-CoV-2ChloroquineECG Electrocardiogram;Rob2 Revised tool for Risk of Bias in randomized trials;CI Confidence interval;Coronavirus InfectionsPost-Exposure ProphylaxisHydroxychloroquinemedicine.drugmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEContext (language use)Antiviral AgentsArticleWHO World Health OrganizationBetacoronavirus03 medical and health sciencesInternal medicineHumansMortalityCOVID-19 Coronavirus disease 2019;Post-exposure prophylaxisPandemicsRetrospective StudiesCQ Chloroquine;SARS-CoV-2ROBINS-I Risk of Bias in Non-randomized Studies of Interventions;business.industryCOVID-19030208 emergency & critical care medicineHydroxychloroquineRetrospective cohort studyHCWs Healthcare workers;NOS Newcastle Ottawa Scale;COVID-19 Drug Treatment030228 respiratory systembusinessHR Hazard Ratio;Journal of Critical Care
researchProduct

Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates

2018

Abstract Background Transrectal prostate biopsy (pbx) is the most frequent outpatient procedure in the urological field. Septic complications are a major health issue. Objective To evaluate complication rates with or without an antimicrobial lubricant. Design, setting, and participants A total of 1000 patients received pbx between 2013 and 2015. Information about complications was collected by a 3-wk questionnaire. Return rate was 73.2% (n = 732). Intervention Randomization for pbx with the instillation of an antimicrobial lubricant (intervention group, n = 385) or the standard lubricant (control group, n = 347) was performed. Outcome measurements and statistical analysis Multivariable anal…

Image-Guided BiopsyMalemedicine.medical_specialtyProstate biopsyFeverUrology030232 urology & nephrologyPatient ReadmissionHematospermialaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRandomized controlled triallawGermanyInternal medicineBiopsymedicineHumansProspective StudiesAgedHematuriaLubricantsmedicine.diagnostic_testbusiness.industryUrinary retentionProstateRectumProstatic NeoplasmsAntibiotic ProphylaxisHemospermiaUrinary RetentionAnti-Bacterial AgentsTransrectal biopsy030220 oncology & carcinogenesisInternational Prostate Symptom Scoremedicine.symptomGastrointestinal HemorrhageComplicationbusinessEuropean Urology Focus
researchProduct

Oral Communication

2012

Inherited factor VII (FVII) deficiency is the most common of the rare autosomal recessive bleeding disorders (RBD), with an estimated prevalence of 1 per 300,000 in European countries.1,2 It is likely that the prevalence is higher in those countries where consanguineous marriages are frequent.We here report STER study results on 112 evaluable enrolled cases

Inherited Factor VII deficiency prophylaxisspontaneous bleeding episodesSettore MED/15 - Malattie Del Sangue
researchProduct

Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adeniti…

2023

ObjectiveTo evaluate the potential role of Streptococcus salivarius K12 (SSK12) in controlling febrile flares in patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome. Further aims were to assess the impact of SSK12 on (i) flare duration, (ii) variation in the degree of the highest body temperature during flares, (iii) steroid-sparing effect, and (iv) change of PFAPA accompanying symptoms before and after SSK12 introduction.Patients and methodsThe medical charts from 85 pediatric patients with PFAPA syndrome (49 males and 36 females) enrolled in the AIDA registry and treated with SSK12 for a median period of 6.00 ± 7.00 months in the period b…

International Registry PFAPA syndrome Streptococcus salivarius K12 autoinflammatory disease probiotic prophylaxis tonsillitisSettore MED/38 - Pediatria Generale E SpecialisticaAutoinflammationGeneral MedicineHuman medicinePFAPA syndromeFrontiers in Medicine
researchProduct